Lattice Biologics (TSXV:LBL.H) Total Assets : C$0.74 Mil (As of Jun. 2021)

View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics Total Assets?

Lattice Biologics's Total Assets for the quarter that ended in Jun. 2021 was C$0.74 Mil.

Total Assets is connected with ROA %. Lattice Biologics's annualized ROA % for the quarter that ended in Jun. 2021 was -16.68%. Total Assets is also linked to Revenue through Asset Turnover. Lattice Biologics's Asset Turnover for the quarter that ended in Jun. 2021 was 0.00.

Lattice Biologics Total Assets Historical Data

The historical data trend for Lattice Biologics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Total Assets Chart

Lattice Biologics Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Sep16

Sep17

Sep18

Sep19

Sep20

Total Assets

Get a 7-Day Free Trial

6.05

4.23

4.00

3.01

3.99

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Total Assets	Get a 7-Day Free Trial															3.36	3.99	3.68	0.79	0.74

Lattice Biologics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Lattice Biologics's Total Assets for the fiscal year that ended in Sep. 2020 is calculated as

Total Assets	=	Total Equity (A: Sep. 2020 )	+	Total Liabilities (A: Sep. 2020 )
	=	-8.469	+	12.461
	=	3.99

Lattice Biologics's Total Assets for the quarter that ended in Jun. 2021 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2021 )	+	Total Liabilities (Q: Jun. 2021 )
	=	0.123	+	0.618
	=	0.74

Lattice Biologics (TSXV:LBL.H) Total Assets Explanation

Total Assets is connected with ROA %.

Lattice Biologics's annualized ROA % for the quarter that ended in Jun. 2021 is

ROA %	=	Net Income (Q: Jun. 2021 )	/	( (Total Assets (Q: Mar. 2021 )	+	Total Assets (Q: Jun. 2021 ))	/ count )
	=	-0.128	/	( (0.794	+	0.741)	/ 2 )
	=	-0.128	/	0.7675
	=	-16.68 %

Note: The Net Income data used here is four times the quarterly (Jun. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Lattice Biologics's Asset Turnover for the quarter that ended in Jun. 2021 is

	Asset Turnover
=	Revenue (Q: Jun. 2021 )	/	( (Total Assets (Q: Mar. 2021 )	+	Total Assets (Q: Jun. 2021 ))	/ count )
=	0	/	( (0.794	+	0.741)	/ 2 )
=	0	/	0.7675
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Lattice Biologics Total Assets Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (TSXV:LBL.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714

Website

http://www.latticebiologics.com

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines